Key result
Failed DES delivery in calcified lesions yields <3% surface damage in most stents, sparing polymer integrity.
Observational (n=42)
Answers are grounded in this paper and cite their sources.
BACKGROUND: Implantation of drug eluting stents (DES) in tortuous and/or calcified vessels is much more demanding compared with implantation of bare metal stents (BMS) due to their larger diameters. It is unknown whether drug eluting stent coatings get damaged while crossing these lesions. METHODS: In 42 patients (34 male, 68.1 +/- 10 years) with 45 calcified lesions (15.9 mm +/- 7.9 mm), DES could not be implanted, even after predilatation. Diabetes was present in 19 patients (45%). Sixty-one stents were used; 19 Cypher select, 18 Taxus Liberté, 10 CoStar, 5 Endeavor RX, 4 Xience V. 3 Janus Carbostent, 1 Yukon Choice S, and 1 Axxion DES. The entire accessible surface area of these stents, in either the unexpanded and expanded state, were examined with an environmental scanning electron microscope (XL30 ESEM, Philips) to evaluate polymer or surface damage. RESULTS: The polymers of Taxus Liberte, Cypher Select, Xience V, CoStar, and Janus DES were only slightly damaged (less than 3% of surface area), whereas the Endeavor RX Stents showed up to 20% damaged surface area. In DES without a polymer (Yukon and Axxion), it could be shown that most of the stent surface (up to 40%) were without any layer of drug. CONCLUSION: Placement of drug eluting stents in tortuous vessels and/or calcified lesions could cause major surface damage by scratching and scraping of the polymer or drug by the arterial wall, even before implantation. There were remarkable differences among the stents examined, only minor damage with the Cypher, Taxus Costar, Janus, and Xience V, whereas the Endeavor, the Yukon, and the Janus DES showed large areas of surface injury.
No takes yet. Share an insight, caveat, or question.
Wiemer et al. (2009) conducted an observational in Calcified and/or tortuous coronary artery lesions with failed drug-eluting stent implantation (n=42). Drug-eluting stents (Cypher Select, Taxus Liberté, CoStar, Endeavor RX, Xience V, Janus Carbostent, Yukon Choice S, Axxion) vs. Comparison across different drug-eluting stent types was evaluated on Polymer or surface damage (% of accessible stent surface area) assessed by environmental scanning electron microscopy. Failed DES implantation in calcified lesions caused <3% surface damage in Taxus, Cypher, Xience V, CoStar, and Janus stents vs up to 20% in Endeavor RX and up to 40% drug loss in polymer-free DES.
Synapse has enriched 10 related papers. Consider them for comparative context: